The trio were convicted of conspiracy to supply unauthorised medicines, including diazepam, zolpidem and zopiclone which are also controlled under the Misuse of Drugs Act, together with other powerful prescription-only medicines (Photo: GEORGES GOBET/AFP/Getty Images).


Indian origin man Jagdiep Dhonsi is one among the three jailed in the UK for his involvement in the illegal supply of potentially dangerous prescription-only medicines.

Jagdiep Dhonsi, Amrin Mirza and Shirina Ali were sentenced on Monday (7) at Southwark Crown Court for their involvement in the crime.

Dhonsi was sentenced to 38 months imprisonment, Mirza to 18 months imprisonment, and Ali to 9 months imprisonment for their roles in the crimes.

Following a complex investigation, the Medicines and Healthcare products Regulatory Agency (MHRA) seized more than 300,000 tablets, worth in excess of £315,000.

It is believed these tablets seized represent a fraction of the overall illegal operation.

The trio were convicted of conspiracy to supply unauthorised medicines, including diazepam, zolpidem and zopiclone which are also controlled under the Misuse of Drugs Act, together with other powerful prescription-only medicines.

The supply of medicines from sources outside the regulated supply chain represents a significant public health risk and the criminal group responsible showed a complete disregard for the public’s safety and well-being.

The medicines the group were supplying can have serious side effects; such as, finasteride, which is used to treat hair loss, can lead to foetal abnormalities and sibutramine, which is used as an appetite suppressant was banned in 2010 because of the health risks associated with its use which include cardiovascular events such as heart attack and stroke.

Alastair Jeffrey, MHRA Head of Enforcement said, “Medicines purchased outside the regulated supply chain cannot be guaranteed to meet standards of quality, safety and effectiveness and can present a real risk to public health. Some may contain dangerous ingredients which can have devastating consequences for patients who use them.

“We work to identify those involved in illegal activities with medicines and will use our powers to investigate fully, confiscate assets and, where necessary, prosecute those putting profit before public health,” he added.